110 related articles for article (PubMed ID: 35476744)
1. Statement from The Memory and Aging Program at Butler Hospital on CMS National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease.
R I Med J (2013); 2022 May; 105(4):75. PubMed ID: 35476744
[No Abstract] [Full Text] [Related]
2. CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease.
Knopman D; Sano M; Feldman HH
Nat Rev Neurol; 2022 Jul; 18(7):379-380. PubMed ID: 35596071
[No Abstract] [Full Text] [Related]
3. CMS Proposes Medicare Coverage Policy for Monoclonal Antibody-Based Alzheimer Treatment.
J Nucl Med; 2022 Mar; 63(3):12N. PubMed ID: 35232884
[No Abstract] [Full Text] [Related]
4. How donanemab data address the coverage with evidence development questions.
Klein EG; Schroeder K; Wessels AM; Phipps A; Japha M; Schilling T; Zimmer JA
Alzheimers Dement; 2024 Apr; 20(4):3127-3140. PubMed ID: 38323738
[TBL] [Abstract][Full Text] [Related]
5. Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
Schulman KA; Greicius MD; Richman B
JAMA; 2021 Aug; 326(5):383-384. PubMed ID: 34279572
[No Abstract] [Full Text] [Related]
6. Medicare Coverage of Aducanumab - Implications for State Budgets.
Sachs RE; Bagley N
N Engl J Med; 2021 Nov; 385(22):2019-2021. PubMed ID: 34797617
[No Abstract] [Full Text] [Related]
7. Detection of novel proteins associated with secondary amyloidosis and Alzheimer's disease by monoclonal antibody.
Yamashita T; Imai K; Saito N; Yachi A
Brain Res; 1988 Dec; 474(2):309-15. PubMed ID: 3208135
[TBL] [Abstract][Full Text] [Related]
8. Medicare and Amyloid PET Imaging: The Battle Over Evidence.
Maschke KJ; Gusmano MK
J Aging Soc Policy; 2017; 29(2):105-122. PubMed ID: 27285978
[TBL] [Abstract][Full Text] [Related]
9. Bariatric surgery complications before vs after implementation of a national policy restricting coverage to centers of excellence.
Dimick JB; Nicholas LH; Ryan AM; Thumma JR; Birkmeyer JD
JAMA; 2013 Feb; 309(8):792-9. PubMed ID: 23443442
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the First Round of Public Comments for the National Coverage Determination for Monoclonal Antibodies in the Treatment of Alzheimer's Disease.
Wahl J; Gadbois EA
J Aging Soc Policy; 2023 Jul; ():1-20. PubMed ID: 37486161
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer's Disease.
Morin PJ; Zhang Q; Xia W; Miller D; Querfurth H; Tahami Monfared AA
Neurol Ther; 2023 Jun; 12(3):721-726. PubMed ID: 36933140
[TBL] [Abstract][Full Text] [Related]
12. Water management program implementation in California hospitals following the Centers for Medicare and Medicaid Services requirement.
Rizzo K; Rosenberg J; Kim J
Am J Infect Control; 2020 Nov; 48(11):1399-1401. PubMed ID: 32387267
[TBL] [Abstract][Full Text] [Related]
13. Commercial negotiated prices for CMS-specified shoppable surgery services in U.S. hospitals.
Jiang JX; Makary MA; Bai G
Int J Surg; 2021 Nov; 95():106107. PubMed ID: 34517136
[No Abstract] [Full Text] [Related]
14. Test limits meet resistance: CMS seeks to restrict new PET scans for Alzheimer's.
Lee J
Mod Healthc; 2013 Jul; 43(27):4. PubMed ID: 23878914
[No Abstract] [Full Text] [Related]
15. The Centers for Medicare and Medicaid Services (CMS) COVID-19 Brief: Unsettling Racial and Ethnic Health Disparities.
Adashi EY; Gruppuso PA
J Am Board Fam Med; 2021 Feb; 34(Suppl):S13-S15. PubMed ID: 33622810
[TBL] [Abstract][Full Text] [Related]
16. Measuring Nonprofit Hospitals' Provision of Charity Care Using IRS and CMS Data.
Gaskin DJ; Herring B; Zare H; Anderson G
J Healthc Manag; 2019; 64(5):293-314. PubMed ID: 31498206
[TBL] [Abstract][Full Text] [Related]
17. The Centers For Medicare And Medicaid Services Hospital Ratings: Pitfalls Of Grading On A Single Curve.
Chung JW; Dahlke AR; Barnard C; DeLancey JO; Merkow RP; Bilimoria KY
Health Aff (Millwood); 2019 Sep; 38(9):1523-1529. PubMed ID: 31479370
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody to amyloid in the brains of patients with Alzheimer's disease.
Ishii T; Sato M; Haga S; Shinoda T; Kato K; Saito T
Neuropathol Appl Neurobiol; 1986; 12(5):441-5. PubMed ID: 3537831
[TBL] [Abstract][Full Text] [Related]
19. Amyloid Hypothesis: The Emperor's New Clothes?
Høilund-Carlsen PF; Barrio JR; Werner TJ; Newberg A; Alavi A
J Alzheimers Dis; 2020; 78(4):1363-1366. PubMed ID: 33164938
[TBL] [Abstract][Full Text] [Related]
20. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.
Selkoe DJ; Bell DS; Podlisny MB; Price DL; Cork LC
Science; 1987 Feb; 235(4791):873-7. PubMed ID: 3544219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
